CompletedPhase 4

Effectiveness of Zinc Supplementation in Management of Patients With Symptomatic Benign Migratory Glossitis

Egypt48 participantsStarted 2021-09-06

Plain-language summary

Effectiveness of Zinc Supplementation in management of patients with symptomatic Benign Migratory Glossitis. Zinc supplements seems to be a therapeutic option as Migratory glossitis is a chronic disease knowing that it needs no treatment. Zinc deficiency can probably be a causative factor in filiform papillae atrophy. Studies have mentioned the role of zinc in wound healing and maintaining a healthy epithelium, as well as regeneration of filiform papillae. Geographic tongue is a disorder that affects the lingual papillae. It has been shown that zinc sulfate can contribute to the treatment of geographic tongue positively.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Both genders are eligible.
✓. Adults above 18 years old.
✓. Patients who presented at the control checkup with constant atrophic areas with raised keratotic margins.
✓. Patients who diagnosed with symptomatic geographic tongue.

Exclusion criteria

✕. Patients with anemia, oral candidiasis, and indicators for localized irritations (dental caries, affected teeth, sharp teeth edges, dental calculus, faulty dental fillings, and faulty prosthetic procedures).
✕. Psoriatic patients.
✕. Vulnerable patients (Prisoners, persons with mental disabilities or physical handicaps, children, neonates and pregnant women)

What they're measuring

Clinical Score

Timeframe: change from baseline at 8 weeks

Subjective Scale

Timeframe: change from baseline at 8 weeks

Trial details

NCT IDNCT05190562

Sponsormariam hamouda

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-01-30

View on ClinicalTrials.gov More Benign Migratory Glossitis trials